LyonsTR, SchedinPJ, BorgesVF. Pregnancy and breast cancer: When they collide. J Mammary Gland Biol Neoplasia, 2009; 14:87–98.
2.
SchedinP, O'BrienJ, RudolphM, et al.Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia, 2007; 12:71–82.
3.
HadjisavvasA, LoizidouMA, MiddletonN, et al.An investigation of breast cancer risk factors in Cyprus: A case control study. BMC Cancer, 2010; 10:447.
4.
EganKM, StampferMJ, RosnerBA, et al.Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev, 1998; 7:359–364.
5.
StuebeAM, WillettWC, XueF, et al.Lactation and incidence of premenopausal breast cancer: A longitudinal study. Arch Intern Med, 2009; 169:1364–1371.
6.
WatsonCJ. Post-lactational mammary gland regression: Molecular basis and implications for breast cancer. Expert Rev Mol Med, 2006; 8:1–15.
7.
KapadiaC, YousefGM, MellatiAA, et al.Complex formation between human kallikrein 13 and serum protease inhibitors. Clin Chim Acta, 2004; 339:157–167.
8.
QinW, ZhangK, KliethermesB, et al.Differential expression of cancer-associated proteins in breastmilk. Breastfeed Med, 2013; 8:120–126.
9.
ChattertonDE, NguyenDN, BeringSB, et al.Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol, 2013; 45:1730–1747.
10.
FlandersKC, WakefieldLM. Transforming growth factor-βs and mammary gland involution; functional roles and implications for cancer progression. J Mammary Gland Biol Neoplasia, 2009; 14:131–144.
11.
EmamiN, DiamandisEP. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers. Clin Chem, 2008; 54:1600–1607.
12.
QinW, ZhangK, KliethermesB, et al.Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancy. BMC Cancer, 2012; 12:100.
13.
KonstantoudakisG, FlorouD, MavridisK, et al.Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas. Clin Biochem, 2010; 43:1205–1211.
14.
ChangA, YousefGM, ScorilasA, et al.Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: An independent indicator of favourable prognosis in breast cancer. Br J Cancer, 2002; 86:1457–1464.
15.
PapachristopoulouG, TalieriM, ScorilasA. Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexate. Tumour Biol, 2013; 34:369–378.
16.
YousefGM, YacoubGM, PolymerisME, et al.Kallikrein gene downregulation in breast cancer. Br J Cancer, 2004; 90:167–172.
17.
BrattsandM, StefanssonK, LundhC, et al.A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol, 2005; 124:198–203.
